TR201902555T4 - Kalp yetmezliği tanısı. - Google Patents
Kalp yetmezliği tanısı. Download PDFInfo
- Publication number
- TR201902555T4 TR201902555T4 TR2019/02555T TR201902555T TR201902555T4 TR 201902555 T4 TR201902555 T4 TR 201902555T4 TR 2019/02555 T TR2019/02555 T TR 2019/02555T TR 201902555 T TR201902555 T TR 201902555T TR 201902555 T4 TR201902555 T4 TR 201902555T4
- Authority
- TR
- Turkey
- Prior art keywords
- igfbp2
- heart failure
- patients
- concentration
- patient
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/4473—Arrangements for investigating the separated zones, e.g. localising zones by electric means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- External Artificial Organs (AREA)
- Paper (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305988 | 2012-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201902555T4 true TR201902555T4 (tr) | 2019-03-21 |
Family
ID=48953397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/02555T TR201902555T4 (tr) | 2012-08-09 | 2013-08-09 | Kalp yetmezliği tanısı. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20150219669A1 (enExample) |
| EP (1) | EP2883057B1 (enExample) |
| JP (2) | JP6298054B2 (enExample) |
| CY (1) | CY1121406T1 (enExample) |
| DK (1) | DK2883057T3 (enExample) |
| ES (1) | ES2713098T3 (enExample) |
| HR (1) | HRP20190341T1 (enExample) |
| HU (1) | HUE042708T2 (enExample) |
| LT (1) | LT2883057T (enExample) |
| PL (1) | PL2883057T3 (enExample) |
| PT (1) | PT2883057T (enExample) |
| RS (1) | RS58553B1 (enExample) |
| SI (1) | SI2883057T1 (enExample) |
| SM (1) | SMT201900108T1 (enExample) |
| TR (1) | TR201902555T4 (enExample) |
| WO (1) | WO2014023820A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3004891T3 (pl) | 2013-06-06 | 2019-09-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarker ponownej hospitalizacji po niewydolności serca |
| US11839614B2 (en) * | 2018-01-31 | 2023-12-12 | Intra-Cellular Therapies, Inc. | Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression |
| EP4056585A4 (en) * | 2019-11-06 | 2024-03-13 | National University Corporation Kagawa University | HEART FAILURE MARKER |
| CN120053474B (zh) * | 2025-02-26 | 2025-12-12 | 浙江大学 | 辅酶a在制备心肌细胞铁死亡抑制剂中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060183681A1 (en) * | 2005-02-14 | 2006-08-17 | Bio-Rad Laboratories, Inc. | Stabilized compositions containing natriuretic peptides |
| JP4465469B2 (ja) * | 2005-02-21 | 2010-05-19 | 国立大学法人佐賀大学 | 循環器病マーカーとしてのインターロイキン１３ |
| EP1722232A1 (en) | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions |
| US20080166734A1 (en) * | 2005-12-21 | 2008-07-10 | David Xing-Fei Deng | Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease |
| JP5399900B2 (ja) * | 2006-06-30 | 2014-01-29 | メルク・シャープ・アンド・ドーム・コーポレーション | Ｉｇｆｂｐ２インヒビター |
| JP2010517023A (ja) | 2007-01-25 | 2010-05-20 | エフ．ホフマン−ラ ロシュ アーゲー | 心不全の評価におけるｉｇｆｂｐ−７の使用 |
| EP2310860A1 (en) * | 2008-07-30 | 2011-04-20 | INSERM - Institut National de la Santé et de la Recherche Médicale | Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure |
| JP6061344B2 (ja) * | 2010-07-14 | 2017-01-18 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイションＣｏｍｍｏｎｗｅａｌｔｈ Ｓｃｉｅｎｔｉｆｉｃ Ａｎｄ Ｉｎｄｕｓｔｒｉａｌ Ｒｅｓｅａｒｃｈ Ｏｒｇａｎｉｓａｔｉｏｎ | 大腸癌の診断 |
| ES2534921T3 (es) * | 2010-08-26 | 2015-04-30 | F. Hoffmann-La Roche Ag | Uso de biomarcadores en la evaluación de la transición temprana de la hipertensión arterial a la insuficiencia cardíaca |
| EP2841945A4 (en) | 2012-04-24 | 2016-04-27 | Astute Medical Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING OF STROKE OR OTHER BRAINS |
| WO2014116708A1 (en) * | 2013-01-22 | 2014-07-31 | Singulex, Inc. | Endothelin in the diagnosis of cardiac disease |
-
2013
- 2013-08-09 WO PCT/EP2013/066697 patent/WO2014023820A1/en not_active Ceased
- 2013-08-09 PT PT13747847T patent/PT2883057T/pt unknown
- 2013-08-09 DK DK13747847.5T patent/DK2883057T3/en active
- 2013-08-09 EP EP13747847.5A patent/EP2883057B1/en active Active
- 2013-08-09 HR HRP20190341TT patent/HRP20190341T1/hr unknown
- 2013-08-09 ES ES13747847T patent/ES2713098T3/es active Active
- 2013-08-09 SM SM20190108T patent/SMT201900108T1/it unknown
- 2013-08-09 JP JP2015525897A patent/JP6298054B2/ja not_active Expired - Fee Related
- 2013-08-09 TR TR2019/02555T patent/TR201902555T4/tr unknown
- 2013-08-09 PL PL13747847T patent/PL2883057T3/pl unknown
- 2013-08-09 RS RS20190247A patent/RS58553B1/sr unknown
- 2013-08-09 HU HUE13747847A patent/HUE042708T2/hu unknown
- 2013-08-09 SI SI201331364T patent/SI2883057T1/sl unknown
- 2013-08-09 LT LTEP13747847.5T patent/LT2883057T/lt unknown
- 2013-08-09 US US14/419,566 patent/US20150219669A1/en not_active Abandoned
-
2018
- 2018-01-12 US US15/869,438 patent/US11061037B2/en active Active
- 2018-02-22 JP JP2018029702A patent/JP6595641B2/ja active Active
-
2019
- 2019-02-25 CY CY20191100229T patent/CY1121406T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180143208A1 (en) | 2018-05-24 |
| CY1121406T1 (el) | 2020-05-29 |
| US11061037B2 (en) | 2021-07-13 |
| JP2015528562A (ja) | 2015-09-28 |
| PL2883057T3 (pl) | 2019-07-31 |
| US20150219669A1 (en) | 2015-08-06 |
| EP2883057A1 (en) | 2015-06-17 |
| EP2883057B1 (en) | 2018-12-05 |
| HUE042708T2 (hu) | 2019-07-29 |
| WO2014023820A1 (en) | 2014-02-13 |
| LT2883057T (lt) | 2019-04-25 |
| RS58553B1 (sr) | 2019-05-31 |
| JP2018109640A (ja) | 2018-07-12 |
| JP6298054B2 (ja) | 2018-03-20 |
| ES2713098T3 (es) | 2019-05-17 |
| PT2883057T (pt) | 2019-03-06 |
| HRP20190341T1 (hr) | 2019-05-31 |
| DK2883057T3 (en) | 2019-03-18 |
| JP6595641B2 (ja) | 2019-10-23 |
| SI2883057T1 (sl) | 2019-07-31 |
| SMT201900108T1 (it) | 2019-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2482078T3 (en) | Cardiovascular disease diagnosis | |
| US10345309B2 (en) | Biomarkers for gastric cancer and uses thereof | |
| CN107110867B (zh) | 用于肝癌诊断的生物标记物及其用途 | |
| JP2019531467A (ja) | 有害事象を示すマーカーとしてのヒストンおよび／またはｐｒｏＡＤＭ | |
| Haas et al. | Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker | |
| Berry et al. | Proteomics analysis reveals IGFBP2 as a candidate diagnostic biomarker for heart failure | |
| JP6595641B2 (ja) | 心不全の診断 | |
| EP3779437A1 (en) | Novel aortic aneurysm marker | |
| Nies et al. | Proteomics discovery of pulmonary hypertension biomarkers: insulin‐like growth factor binding proteins are associated with disease severity | |
| Lewandowicz et al. | Changes in urine proteome accompanying diabetic nephropathy progression. | |
| US20090226937A1 (en) | Methods for the Detection and Monitoring of Congestive Heart Failure | |
| Snipsøyr et al. | Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis | |
| WO2015157546A1 (en) | Protein biomarkers for immune assessment and prediction of transplant rejection | |
| Johansson et al. | Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers | |
| US10557860B2 (en) | Circulating pulmonary hypertension biomarker | |
| Overgaard et al. | Quantitative iTRAQ-based proteomic identification of candidate biomarkers for diabetic nephropathy in plasma of type 1 diabetic patients | |
| KR102475926B1 (ko) | 전신 홍반성 루푸스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루푸스 진단에 필요한 정보를 제공하는 방법 | |
| US20110256169A1 (en) | Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use | |
| WO2023013764A1 (ja) | 非アルコール性脂肪性肝炎における線維化進行度および／または前記肝疾患の活動性を推定する方法 | |
| US20220202828A1 (en) | Insulin-like growth factor axis proteins as circulating pulmonary arterial hypertension biomarkers | |
| Scebba et al. | Differential proteome profile in ischemic heart disease: Prognostic value in chronic angina versus myocardial infarction. A proof of concept | |
| Trenchevska et al. | Association of cystatin C proteoforms with estimated glomerular filtration rate | |
| Ucciferri et al. | Differential proteome profile in ischemic heart disease: Prognostic value in chronic angina versus myocardial infarction. A proof of concept | |
| Koukoui et al. | IJC Metabolic & Endocrine | |
| KR20080091234A (ko) | 신장 질환의 진단 방법 및 이를 위한 마커 |